1950-15-8

Basic information

• Product Name: sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate
• Synonyms: sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate;5,6-Dihydro-5-benzyl-6-thioxo-2H-1,3,5-thiadiazine-3(4H)-acetic acid sodium salt
• CAS NO: 1950-15-8
• Molecular Formula: C12H13N2NaO2S2
• Molecular Weight: 304.36359
• EINECS: 217-766-9
• Mol File: 1950-15-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 472.3°Cat760mmHg
• Flash Point: 239.4°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 1E-09mmHg at 25°C
• CAS DataBase Reference: sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate(CAS DataBase Reference)
• NIST Chemistry Reference: sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate(1950-15-8)
• EPA Substance Registry System: sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate(1950-15-8)

Safety Data

• Hazardous Substances Data: 1950-15-8(Hazardous Substances Data)

Usage

Description

Sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate is a chemical compound belonging to the thiadiazine class, known for its potential pharmaceutical applications. As a derivative of thiadiazine, it has been studied for its anticonvulsant and neuroprotective properties. The sodium salt form of this compound is believed to enhance its solubility and bioavailability, making it a promising drug candidate. Its structure indicates a possible role as a modulator of central nervous system function, with potential activity against seizures and neurodegenerative disorders. Further research is essential to fully elucidate its pharmacological properties and potential therapeutic applications.

Uses

Used in Pharmaceutical Industry:
Sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate is used as a potential anticonvulsant agent for the treatment of seizure disorders. Its neuroprotective properties make it a candidate for the development of therapies targeting neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
Used in Research and Development:
In the field of pharmaceutical research and development, sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate serves as a valuable compound for studying the modulation of central nervous system function. Its potential as a modulator of neurotransmission and neuroprotection is of interest to scientists working on novel treatments for neurological conditions.
Used in Drug Formulation:
Sodium 5-benzyl-6-thioxodihydro-2H-1,3,5-thiadiazine-3(4H)-acetate is used in drug formulation to improve the solubility and bioavailability of the compound, enhancing its effectiveness as a therapeutic agent. The sodium salt form may facilitate better absorption and distribution within the body, leading to improved pharmacokinetics and therapeutic outcomes.

InChI:InChI=1/C12H14N2O2S2.Na/c15-11(16)7-13-8-14(12(17)18-9-13)6-10-4-2-1-3-5-10;/h1-5H,6-9H2,(H,15,16);/q;+1/p-1